期刊文献+

大麻素受体在溃疡性结肠炎患者血清和肠组织中的表达 被引量:5

Expressions of cannabinoid receptor in serum and intestinal tissue with ulcerative colitis
下载PDF
导出
摘要 目的检测大麻素受体1(CNR1)和大麻素受体2(CNR2)在溃疡性结肠炎(UC)患者血清和肠组织中的表达,探讨其与UC的关系及临床意义。方法连续收集35例UC(UC组)、20例已排除炎症性肠病的普通肠炎患者(疾病对照组)和15例肠黏膜病理正常者(正常对照组),用酶联免疫吸附(ELISA)法检测其血清中CNR1、CNR2、C反应蛋白(CRP)和白介素(IL)-10表达水平;免疫组化法检测肠道黏膜中CNR1和CNR2的表达情况。结果 UC患者血清中CNR1、CNR2含量明显高于两个对照组(P<0.05)。UC活动期血清中CNR1、CNR2、IL-10表达量要低于缓解期,而CRP高于缓解期(P<0.01)。UC肠道黏膜CNR1、CNR2表达率明显高于普通肠炎黏膜以及正常肠黏膜(P<0.05),而后两者相比差异无统计学意义。结论 CNR在UC中表达显著上调,表明CNR对UC的发生发展可能起着重要作用。 Objective To detect the expressions of cannabinoid receptor 1 ( CNR1 ) and CNR2 in patients with ul- cerative colitis (UC) in serum and intestinal tissue; to explore its relationship with the UC and its clinical signifi- cance. Methods 35 patients with ulcerative colitis (UC), 20 patients with other non-IBD gastrointestinal conditions( disease control group) and 15 pathology of the normal intestinal mucosa(normal control group), its the levels of serum CNR1, CNR2, C-reactive protein (CRP) and interleukin-10 (IL-10) were measured by enzyme-linked im- munosorbent assay ( ELISA ) . The immunohistochemical method was used to detect the expression of these intestinal mucosa CNR1 and CNR2. Results Compared with non-IBD gastrointestinal conditions and normal controls, the levels of serum CNR1, CNR2 in UC patients were significantly increased. UC activity of serum CNR1, CNR2 and IL- 10 expression level is lower than that in remission period, and CRP is higher than patients in remission period (P 〈 0. 01 ). The intestinal mucosa of UC CNR1, CNR2 expression was significantly higher than the ordinary of enteritis mucosa and pathological normal intestinal mucosa (P 〈 0.05 ), the latter two showed no significant difference. Conclusion CNR in the UC patients expresses significant increase, which suggests that CNR may play an important role in occurrence and development of UC.
出处 《安徽医科大学学报》 CAS 北大核心 2013年第2期160-163,共4页 Acta Universitatis Medicinalis Anhui
关键词 溃疡性结肠炎 大麻素受体1 大麻素受体2 IL-10 ulcerative colitis cannabinoid receptor 1 cannabinoid receptor 2 IL-10
  • 相关文献

参考文献1

二级参考文献15

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 3樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.
  • 4欧阳钦.炎症性肠病的诊治进展.见:孟宪镛主编.实用消化病诊疗学.第2版.上海:世界图书出版社,2006.362-84.
  • 5Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol,2005: 21:408-413.
  • 6Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, con sensus, and implications. Gut, 2006, 55:749-753.
  • 7Zheng JJ. Clinical aspects of ulcerative colitis in China's Mainland. Chin J Dig Dis, 2006, 7:71-75.
  • 8Hanauer SB, Sandborn W, Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol, 2001, 96: 635- 643.
  • 9Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut, 2006, 55 Suppl 1:i1- i15.
  • 10Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut, 2004, 53 Suppl 5: Ⅴ1-Ⅴ16.

共引文献1020

同被引文献49

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部